Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience

被引：0
|
作者：
Gogia, A. [1 ]
Raina, V. [1 ]
Sharma, A. [1 ]
Kumar, L. [1 ]
机构：
[1] All India Inst Med Sci, Delhi, India
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3627
引用
收藏
页码：S844 / S845
页数：2
相关论文
共 50 条
  • [21] The management of lymphoma and chronic lymphocytic leukaemia patients on long term intravenous immunoglobulin replacement therapy: a single centre experience
    Webster, Bethany
    Elmusharaf, Nagah
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 178 - 179
  • [22] A single centre study to assess delivery of vaccination advice to patients with chronic lymphocytic leukaemia
    Cox, Grace
    Allsup, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 186 - 186
  • [23] Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
    Chow, Kai Uwe
    Kim, Soo-Zin
    von Neuhoff, Nils
    Schlegelberger, Brigitte
    Stilgenbauer, Stephan
    Wunderle, Lydia
    Cordes, Hans-Joerg
    Bergmann, Lothar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (05) : 426 - 433
  • [24] Efficacy and safety of Voriconazole in immunocompromised patients - single centre experience
    Wojcik, Dorota
    Pietras, Wojciech
    Sega-Pondel, Dorota
    Celuch, Beata
    Kalwak, Krzysztof
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 181 - 184
  • [25] The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
    Eyre, Toby A.
    Roeker, Lindsey E.
    Fox, Christopher P.
    Gohill, Satyen H.
    Walewska, Renata
    Walter, Harriet S.
    Forconi, Francesco
    Broom, Angus
    Arumainathan, Arvind
    Brander, Danielle M.
    Allan, John N.
    Schuster, Stephen J.
    Hill, Brian T.
    Lansigan, Frederick
    Cheson, Bruce D.
    Lamanna, Nicole
    Coombs, Catherine C.
    Barr, Paul M.
    Skarbnik, Alan P.
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Pearson, Laurie
    Pagel, John M.
    Jacobs, Ryan
    Mato, Anthony R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : 918 - 923
  • [26] FCR AS FIRST LINE TREATMENT FOR PATIENTS WITHOUT COMORBIDITIES WITH CHRONIC LYMPHOCYTIC LEUKAEMIA: EXPERIENCE OF A CENTRE
    Juan Luis, Reguera Ortega
    Vadillo Irene, Sanchez
    Alvarez Teresa, De Soto
    Ortigueira Mar, Meijon
    Velandia Angelica, Martinez
    Martin Isabel, Goyanes
    Clemente Susan, Cortez
    Tello Patricia, Baltasar
    Yuste Victor, Jimenez
    Albendea Miguel, Canales
    HAEMATOLOGICA, 2016, 101 : 336 - 336
  • [27] Venetoclax plus rituximab for chronic lymphocytic leukaemia
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (05): : E233 - E233
  • [28] Safety and efficacy of bendamustine and rituximab (BR) regimen in Indian chronic lymphocytic leukemia patients
    Gogia, A.
    Kumar, L.
    Sharma, A.
    Raina, V.
    Gupta, R.
    Rani, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] EFFICACY AND SAFETY OF BIOSIMILAR RITUXIMAB IN BIOLOGIC NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: A SINGLE CENTRE EXPERIENCE FROM KERALA, INDIA
    Ravindran, Vinod
    RHEUMATOLOGY, 2015, 54 : 79 - 80
  • [30] Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience
    Ozmen, Deniz
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Sadri, Sevil
    Salihoglu, Ayse
    Eskazan, Ahmet Emre
    Ar, M. Cem
    Ongoren, Seniz
    Baslar, Zafer
    Soysal, Teoman
    BLOOD, 2017, 130
12345